Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...
The "Liquid Biopsy Market Report by Product, Application, Circulating Biomarkers, End-User Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. Liquid ...
Lunit’s new collaboration with Daiichi Sankyo integrates AI-driven digital pathology tools into oncology translational ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ: WHWK ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that Providence Swedish Cancer Institute and the ...
Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025, VolitionRx (NYSE:VNRX) made a significant milestone announcement that, for the first time, Nu.Q Discover biomarkers will be ...
Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...
When Nathan was diagnosed with chronic lymphocytic leukemia (CLL) at just 45 years old, his world turned upside down overnight. As a military veteran and ER nurse, he was no stranger to facing ...
"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback